With such a low market cap and MM121 positive data readouts coming by the end of the year. does anyone else here think it's possible Sanofi could step up and look to takeout Merrimack early on the cheap? I think this in combination combination with too much potential in the pipeline and lack of CASH resources for Merrimack will result in an inability to survive as an independent biopharmaceutical company. Sanofi most likely to step up. Any thoughts?
Yup they are not into the money. They have money enough to pay their bloated salaries for the next 5 years.
I think you meant Nobel piece prize?
Please get back to the front desk and order up some pieces of pizza. And stay at the front desk. That should suffice for now.